Back to today’s briefing

Story perspectives

New Initiative Launches Vaccine Trials Against Lassa Fever, Malaria

8/12/2025

50 11

Summary

Story summary

The ENABLE 1.5 Lassa Research Programme has kicked off in West Africa, targeting the dual threat of Lassa fever and malaria. With funding from CEPI, the initiative plans to enroll 5,000 participants in Liberia, Nigeria, and Sierra Leone from late 2024 to mid-2026, paving the way for vital vaccine trials and bolstering community preparedness for immunization.

1 of 1

Story summary

The ENABLE 1.5 Lassa Research Programme has kicked off in West Africa, targeting the dual threat of Lassa fever and malaria. With funding from CEPI, the initiative plans to enroll 5,000 participants in Liberia, Nigeria, and Sierra Leone from late 2024 to mid-2026, paving the way for vital vaccine trials and bolstering community preparedness for immunization.